Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Solesence (SLSN) EBIT (2016 - 2025)

Historic EBIT for Solesence (SLSN) over the last 16 years, with Q3 2025 value amounting to -$781000.0.

  • Solesence's EBIT fell 12442.15% to -$781000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 6640.65%. This contributed to the annual value of $5.1 million for FY2024, which is 24472.65% up from last year.
  • According to the latest figures from Q3 2025, Solesence's EBIT is -$781000.0, which was down 12442.15% from $1.9 million recorded in Q2 2025.
  • Solesence's EBIT's 5-year high stood at $3.2 million during Q3 2024, with a 5-year trough of -$1.9 million in Q4 2023.
  • In the last 5 years, Solesence's EBIT had a median value of $123000.0 in 2022 and averaged $172368.4.
  • As far as peak fluctuations go, Solesence's EBIT surged by 125581.4% in 2021, and later crashed by 105619.05% in 2023.
  • Over the past 5 years, Solesence's EBIT (Quarter) stood at -$299000.0 in 2021, then plummeted by 519.4% to -$1.9 million in 2022, then decreased by 2.43% to -$1.9 million in 2023, then surged by 88.24% to -$223000.0 in 2024, then plummeted by 250.22% to -$781000.0 in 2025.
  • Its EBIT stands at -$781000.0 for Q3 2025, versus $1.9 million for Q2 2025 and $256000.0 for Q1 2025.